Tumor sphere assay conducted using cells with stably silenced (SCC15-CD44+) or overexpressed (CAL27-CD44+) METTL3 showed that METTL3 upregulation promoted CD44(+) self-renewal potential (Fig. 2G, H). This evidence concerns the gene CD44 and neoplasm.